Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia

Nidhogg Resources Holding AB (publ)

17/01/2023 20:33

Jan 17 (Reuters) - Eurocine Vaccines AB  EUCI.TE :
    * EUROCINE VACCINES DECIDES TO DEVELOP MRNA-BASED VACCINE
CANDIDATE AGAINST CHLAMYDIA
    * EUROCINE VACCINES - AT SAME TIME, COMPANY DECIDES TO PAUSE
RESOURCE-INTENSIVE DEVELOPMENT OF PROTEIN-BASED CHLAMYDIA
CANDIDATE UNTIL FURTHER NOTICE
    * EUROCINE VACCINES-GOAL IS TO CONDUCT PRECLINICAL
STUDIES,EARLY
MRNA DEVELOPMENT IN NEAR TERM,TO BEGIN PROCESS DEVELOPMENT,OTHER
PREPARATIONS Q4 2023 

Source text for Eikon: nWkr7BSfNY
Further company coverage:  EUCI.TE 
 ((Reuters.Briefs@thomsonreuters.com;))